Leprosy Skin Test Antigens Trial

NCT00128193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

260

Enrollment

NIH

Sponsor class

Conditions

Leprosy

Interventions

BIOLOGICAL: Tuberculin, Purified Protein Derivative
OTHER: MLSA-LAM
OTHER: MLCwA
BIOLOGICAL: Tuberculin, Purified Protein Derivative
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)